 Effect acarbose carbohydrate lipid metabolism NIDDM patients sulfonylureas ability acarbose plasma glucose concentration patients non-insulin-dependent diabetes NIDDM diet sulfonylurea drugs Patients mo addition acarbose treatment program significant improvement glycemic control decrease plasma glucose concentration modest mM average postprandial plasma glucose concentration mM acarbose therapy patients glucose levels pretreatment levels addition improvement glycemia acarbose treatment significant reduction triglyceride mM concentrations plasma insulin response meals insulin-stimulated glucose uptake acarbose therapy consistent view acarbose improves glycemic control glucose absorption Considerable individual variation response results patients dramatic striking reductions fasting postprandial glucose concentrations addition acarbose patients NIDDM sulfonylureas significant clinical benefit